Immunovant, Inc.

IMVT

$33.30

Name : Immunovant, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $6,878,204,416.00

EPSttm : -2.81

Immunovant, Inc.

$33.30

2.06%

$0.7

IMVT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

20.34

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

0.08

EPS Last/This Y

-0.07

EPS This/Next Y

0.09

Price

33.3

Target Price

48.88

Analyst Recom

1.47

Performance Q

-14.29

Upside

-209.7%

Beta

0.83

Ticker: IMVT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	IMVT	41.21	0.16	8.18	26794
2026-08-31	IMVT	40.8	0.16	0.10	26833
2026-09-01	IMVT	39.92	0.15590162539358	0.47245762711864	27166
2026-09-02	IMVT	39.48	0.16	1.73	27844
2026-09-03	IMVT	39.12	0.17	1.00	27995
2026-09-04	IMVT	39.24	0.17	0.03	27992
2026-09-08	IMVT	39.55	0.17	0.12	27982
2026-09-09	IMVT	38.72	0.16	0.18	28314
2026-09-10	IMVT	38.09	0.17	0.14	28655
2026-09-11	IMVT	37.15	0.17	8.42	28672
2026-09-14	IMVT	37.62	0.17	0.02	28719
2026-09-15	IMVT	36.64	0.17	6.08	28722
2026-09-16	IMVT	36.43	0.17	1.68	28794
2026-09-17	IMVT	37.63	0.17	0.00	28799
2026-09-18	IMVT	36.93	0.17	0.05	28837
2026-09-21	IMVT	37.2	0.12	0.23	23325
2026-09-22	IMVT	37.27	0.12	0.58	23432
2026-09-23	IMVT	34.53	0.12	0.00	23502
2026-09-24	IMVT	34.11	0.12	0.24	24236
2026-09-25	IMVT	33.3	0.12	0.35	24469
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	IMVT	41.19	-11.4	-	-2.84
2026-08-31	IMVT	40.82	-11.4	-	-2.84
2026-09-01	IMVT	39.90	-11.4	-	-2.84
2026-09-02	IMVT	39.49	-11.4	-	-2.84
2026-09-03	IMVT	39.26	-11.4	-	-2.84
2026-09-04	IMVT	39.28	-11.4	-	-2.84
2026-09-08	IMVT	39.51	-11.4	-	-2.84
2026-09-09	IMVT	38.74	-11.4	-	-2.84
2026-09-10	IMVT	38.06	-11.4	-	-2.84
2026-09-11	IMVT	37.35	-11.4	-	-2.84
2026-09-14	IMVT	37.65	-11.4	-	-2.84
2026-09-15	IMVT	36.63	-11.4	-	-2.84
2026-09-16	IMVT	36.63	-11.4	-	-2.84
2026-09-17	IMVT	37.66	-11.4	-	-2.84
2026-09-18	IMVT	36.94	-11.4	-	-2.84
2026-09-21	IMVT	37.16	-11.4	-	-2.84
2026-09-22	IMVT	37.27	-11.4	-	-2.84
2026-09-23	IMVT	34.55	-11.4	-	-2.84
2026-09-24	IMVT	34.03	-11.4	-	-2.84
2026-09-25	IMVT	33.30	-11.4	-	-2.84
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	IMVT	-0.34	-0.42	20.10
2026-08-31	IMVT	-0.34	-0.44	20.10
2026-09-01	IMVT	-0.34	-0.44	20.10
2026-09-02	IMVT	-0.34	-0.44	20.10
2026-09-03	IMVT	-0.34	-0.44	20.10
2026-09-04	IMVT	-0.34	-0.44	20.10
2026-09-08	IMVT	-0.34	-0.43	20.10
2026-09-09	IMVT	-0.34	-0.43	20.10
2026-09-10	IMVT	-0.34	-0.43	20.10
2026-09-11	IMVT	-0.34	-0.43	18.69
2026-09-14	IMVT	-0.34	-0.42	18.69
2026-09-15	IMVT	-0.34	-0.42	18.69
2026-09-16	IMVT	-0.34	-0.42	18.69
2026-09-17	IMVT	-0.34	-0.42	18.69
2026-09-18	IMVT	-0.34	-0.42	18.69
2026-09-21	IMVT	-0.34	-0.42	18.61
2026-09-23	IMVT	-0.34	-0.42	18.61
2026-09-24	IMVT	-0.34	-0.42	18.61
2026-09-25	IMVT	-0.34	-0.42	20.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.75

Avg. EPS Est. Current Quarter

-0.72

Avg. EPS Est. Next Quarter

-0.67

Insider Transactions

-0.34

Institutional Transactions

-0.42

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

26.9

Max Drawdown 5-Year %

-69.9

Target Price

48.88

P/E

Forward P/E

PEG

P/S

P/B

9.34

P/Free Cash Flow

EPS

-2.81

Average EPS Est. Cur. Y

-2.84

EPS Next Y. (Est.)

-2.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.64

Return on Equity vs Sector %

-99.5

Return on Equity vs Industry %

-79.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

-0.32

EBIT Estimation

◆ IMVT Healthcare

$33.30

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

5/25

Volume

3/15

Valuation

10/20

TP/AR

4/10

Options

8/10

RSI

25.1

Range 1M

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

13/25

Growth

5/30

Estimates

2/20

Inst/Vol

4/15

Options

8/10

EPS Yr

-6%

EPS NY

0.6%

52W%

59.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +46.8% upside

Quality

2/30

Valuation

10/30

Growth

2/25

Stability

6/10

LT Trend

1/5

Upside

+46.8%

Quality

IMVT — P/E HistoricalBiotechnology

Immunovant, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 315

Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

IMVT

Latest News

—

Caricamento notizie per IMVT…

stock quote shares IMVT – Immunovant Inc Stock Price stock today

news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch IMVT – Immunovant Inc yahoo finance google finance

stock history IMVT – Immunovant Inc invest stock market

stock prices IMVT premarket after hours

ticker IMVT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMVT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y